The last decade has seen the complexity, size, and costs of clinical trials increase, which has made the task of guaranteeing data quality progressively difficult.
Marc Buyse
Advertisement
Marc Buyse, ScD, is director, International Drug Development Institute (IDDI), Brussels, Belgium,+32 2 6468918, fax: +32 2 6468662, email: marc.buyse@iddi.com.
Articles by Marc Buyse
The final version of the EMA Reflection Paper on Risk Based Quality Management in Clinical Trials is now available.
Advertisement
Latest Updated Articles
Centralized Statistical Monitoring As a Way to Improve the Quality of Clinical DataPublished: March 24th 2014 | Updated:
EMA Reflection Paper on Risk Based Quality Management in Clinical TrialsPublished: December 11th 2013 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Applied Clinical Trials' 2025 State of the Industry Survey
2
Are Clinical Trial Diversity Initiatives at Risk of Being Dismantled?
3
Enhancing Data Quality and Real-World Evidence in Clinical Research
4
Beyond the Comment Section: Rebuilding Trust in Vaccines Through Conversation
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
